# BayMed Venture Partners

BayMed Venture Partners is a Venture Capital based in San Francisco, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** www.baymedvp.com

## Regulatory record

- **CRD number:** 333295
- **Registration status:** Registered
- **Latest Form ADV filing:** 2026-03-31T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0

## About

BayMed Venture Partners identifies and mentors innovative maturing early-stage medical device and digital health companies in North America and Israel. The firm focuses on unmet clinical needs and disruptive innovation, applying deep clinical and operational expertise. It aims to advance breakthrough solutions that deliver value for portfolio companies, investment partners, and the global healthcare system.

## Sectors

- Digital Health
- Healthcare Services
- Medical Devices

## People

- Gary Gershony — MD — Founding General Partner
- Neil Meyer — Founding General Partner
- Gregg W. Stone — MD — Advisor and clinical key opinion leader
- Leslie Saxon — MD — Advisor and digital health key opinion leader
- Martin T. Rothman — MD — Advisor and industry key opinion leader
- Amanda White — Senior Associate

## Questions

### What investment stages does BayMed Venture Partners target?

BayMed invests across early-stage, expansion, and growth-stage companies. The firm's stage flexibility reflects the capital-intensive nature of life sciences, where companies often need funding through clinical trials, regulatory approvals, and early commercialization before reaching revenue scale. This multi-stage approach allows BayMed to support portfolio companies from pre-revenue R&D through market expansion.

### Which healthcare subsectors does BayMed focus on?

The firm targets the convergence of technology and life sciences, with a mandate spanning medical devices, digital health, and healthcare services. BayMed's thesis centers on innovations that navigate the intersection of clinical science and commercial scalability — companies that require both technical validation and regulatory clearance to reach the market.

### Does BayMed Venture Partners manage a single fund or multiple vehicles?

Public records do not confirm the firm's specific fund structure, total assets under management, or number of vehicles. BayMed's website provides limited disclosure on fundraising history. Institutional allocators should request fund-level track records and vehicle documentation directly from the firm.

### Is BayMed Venture Partners registered with the SEC as an investment adviser?

Registration status is not confirmed through the firm's limited public disclosures. Institutional counterparties conducting due diligence should verify BayMed's regulatory filings and Form ADV through the SEC's Investment Adviser Public Disclosure database to determine registration status, disciplinary history, and reported assets.

## Related profiles

- [Baymark Partners](https://altss.com/profile/baymark-partners)
- [Baynes Investment Counsel](https://altss.com/profile/baynes-investment-counsel)

---

Updated: 2026-08-11T15:06:13.093Z

Canonical page: https://altss.com/profile/baymed-venture-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology